The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Blockchain Technology for Detecting Falsified and Substandard Drugs in Distribution: Pharmaceutical Supply Chain Intervention
Open accessAbstract
BACKGROUND: Drug counterfeiting is a global problem with significant risks to consumers and the general public. In the Philippines, 30% of inspected drug stores in 2003 were found with substandard/spurious/falsely-labeled/falsified/counterfeit drugs. The economic burden on the population drug expenditures and on governments is high. The Philippine Food and Drug Administration (FDA) encourages the public to check the certificates of product registration and report any instances of counterfeiting. The National Police of Philippines responds to such reports through a special task force. However, no literature on its impact on the distribution of such drugs were found. Blockchain technology is a cryptographic ledger that is allegedly immutable through repeated sequential hashing and fault-tolerant through a consensus algorithm. This project will develop and test a pharmacosurveillance blockchain system that will support information sharing along the official drug distribution network. OBJECTIVE: This study aims to develop a pharmacosurveillance blockchain system and test its functions in a simulated network. METHODS: We are developing a Distributed Application (DApp) that will run on smart contracts, employing Swarm as the Distributed File System (DFS). Two instances will be developed: one for Ethereum and another for Hyperledger Fabric. The proof-of-work (PoW) consensus algorithm of Ethereum will be modified into a delegated proof-of-stake (DPoS) or practical Byzantine fault tolerance (PBFT) consensus algorithm as it is scalable and fits the drug supply chain environment. The system will adopt the GS1 pedigree standard and will satisfy the data points in the data standardization guidelines from the US FDA. Simulations will use the following 5 nodes: for FDA, manufacturer, wholesaler, retailer, and the consumer portal. RESULTS: Development is underway. The design of the system will place FDA in a supervisory data verification role, with each pedigree type-specific data source serving a primary data verification role. The supply chain process will be initiated by the manufacturer, with recursive verification for every transaction. It will allow consumers to scan a code printed on the receipt of their purchases to review the drug distribution history. CONCLUSIONS: Development and testing will be conducted in a simulated network, and thus, results may differ from actual practice. The project being proposed is disruptive; once tested, the team intends to engage the Philippine FDA to discuss implementation plans and formulate policies to facilitate adoption and sustainability. REGISTERED REPORT IDENTIFIER: RR1-10.2196/10163.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Unified Theory of Acceptance and Use of Technology: A Synthesis and the Road Ahead
University of Arkansas, Venkatesh, V., Thong, J., Hong Kong University of Science and Technology, Xu, X., & The Hong Kong Polytechnic University (2016) · Journal of the Association for Information Systems · doi:10.17705/1jais.00428 · Cited by 2,513
A review of existing and emerging digital technologies to combat the global trade in fake medicines
Mackey, T. K., & Nayyar, G. (2017) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2017.1313227 · Cited by 361
The Global Threat of Counterfeit Drugs: Why Industry and Governments Must Communicate the Dangers
Cockburn, R., Newton, P. N., Agyarko, E. K., Akunyili, D., & White, N. J. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020100 · Cited by 330
Tamper-Resistant Mobile Health Using Blockchain Technology.
Ichikawa, D., Kashiyama, M., & Ueno, T. (2017) · JMIR mHealth and uHealth · doi:10.2196/mhealth.7938 · Cited by 298 · cited 1×
“The more the nodes in the network, the less likely it is to fail [17].”
BackgroundSubstandard drugs: a potential crisis for public health
Johnston, A., & Holt, D. W. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12298 · Cited by 270
Substandard/Counterfeit Antimicrobial Drugs
Kelesidis, T., & Falagas, M. E. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00072-14 · Cited by 236
The health and economic effects of counterfeit drugs.
Blackstone, E. A., Fuhr, J. P., & Pociask, S. (2014) · Europe PMC (PubMed Central) · Cited by 189
The environment needs cryptogovernance
Chapron, G. (2017) · Nature · doi:10.1038/545403a · Cited by 159
Spurious and counterfeit drugs: a growing industry in the developing world
Gautam, C. S., Utreja, A., & Singal, G. L. (2009) · Postgraduate Medical Journal · doi:10.1136/pgmj.2008.073213 · Cited by 92
Pharmaceutical Policy in Countries with Developing Healthcare Systems
Babar, Z. (2017) · Springer eBooks · doi:10.1007/978-3-319-51673-8 · Cited by 72
Cited by
Dutta, P., Choi, T.-M., Somani, S., & Butala, R. (2020) · Transportation Research Part E: Logistics and Transportation Review · doi:10.1016/j.tre.2020.102067 · Cited by 1,545
Blockchain Technology in Healthcare: A Comprehensive Review and Directions for Future Research
Khezr, S., Moniruzzaman, M., Yassine, A., & Benlamri, R. (2019) · Applied Sciences · doi:10.3390/app9091736 · Cited by 575
Applications of blockchain technology in medicine and healthcare: challenges and future perspectives
Siyal, A. A., Junejo, A. Z., Zawish, M., Ahmed, K., Khalil, A., & Soursou, G. (2019) · Cryptography · doi:10.3390/cryptography3010003 · Cited by 531
Leng, J., Ruan, G., Jiang, P., Xu, K., Liu, Q., Zhou, X., & Liu, C. (2020) · Renewable and Sustainable Energy Reviews · doi:10.1016/j.rser.2020.110112 · Cited by 506
Transparency in food supply chains: A review of enabling technology solutions
Astill, J., Dara, R. A., Campbell, M., Farber, J. M., Fraser, E. D. G., Sharif, S., & Yada, R. Y. (2019) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2019.07.024 · Cited by 483
Collaborative Networks: Integrating Blockchain for Enhanced Trust and Transparency
Kumar, A., & Prakash Roy, O. (2024) · International Journal of Innovative Science and Research Technology (IJISRT) · doi:10.38124/ijisrt/ijisrt24jul180 · Cited by 449
Lim, M. K., Li, Y., Wang, C., & Tseng, M.-L. (2021) · Computers & Industrial Engineering · doi:10.1016/j.cie.2021.107133 · Cited by 382
Blockchain platform for industrial healthcare: Vision and future opportunities
Farouk, A., Alahmadi, A., Ghose, S., & Mashatan, A. (2020) · Computer Communications · doi:10.1016/j.comcom.2020.02.058 · Cited by 335
Mackey, T. K., Kuo, T.-T., Gummadi, B., Clauson, K. A., Church, G., Grishin, D., Obbad, K., Barkovich, R., & Palombini, M. (2019) · BMC Medicine · doi:10.1186/s12916-019-1296-7 · Cited by 318
Blockchain-enabled supply chain: analysis, challenges, and future directions
Jabbar, S., Lloyd, H., Hammoudeh, M., Adebisi, B., & Raza, U. (2021) · Multimedia Systems · doi:10.1007/s00530-020-00687-0 · Cited by 307
A Systematic Review of Blockchain in Healthcare: Frameworks, Prototypes, and Implementations
Chukwu, E., & Garg, L. (2020) · IEEE Access · doi:10.1109/access.2020.2969881 · Cited by 277
A Patient-Centric Health Information Exchange Framework Using Blockchain Technology
Zhuang, Y., Sheets, L. R., Chen, Y.-W., Shae, Z.-Y., Tsai, J. J. P., & Shyu, C.-R. (2020) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2020.2993072 · Cited by 265
A Review of Blockchain-Based Systems in Transportation
Astarita, V., Giofrè, V. P., Mirabelli, G., & Solina, V. (2019) · Information · doi:10.3390/info11010021 · Cited by 180
Mackey, T. K., & Cuomo, R. E. (2020) · Global Health Action · doi:10.1080/16549716.2019.1695241 · Cited by 87
Saeed, G., Kohler, J. C., Cuomo, R. E., & Mackey, T. K. (2022) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2022.2091543 · Cited by 33
Metadata
- Authors
- Sylim, P., Liu, F., Marcelo, A., & Fontelo, P.
- Venue
- JMIR Research Protocols
- Publisher
- JMIR Publications Inc.
- Published
- 2018-09-13
- Volume
- 7
- Issue
- 9
- Pages
- e10163
- ISSN
- 1929-0748 (ISSN-L)
- OpenAlex
- W2820243612
- Cited by
- 269
- References
- 10
- FWCI
- 42.98
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.